Reminyl name change no remedy
Pharmacists are reporting confusion between Takeda's sleep aid Rozerem (ramelteon) and J&J's Alzheimer's therapy Razadyne (galantamine), according to the Institute for Safe Medication Practice's Medication Safety Alert. Name confusion is not a new problem for the J&J product; formerly Reminyl, the company renamed galantamine Razadyne in 2005 due to confusion with Sanofi-Aventis' anti-diabetic Amaryl (glimepiride) (1"The Pink Sheet" Jan. 10, 2005, p. 8)...
You may also be interested in...
Janssen's name change for its Reminyl Alzheimer's products gives the company a fresh platform for promoting the galantamine extended-release formulation approved by FDA Dec. 22
Device Week, 05 March - Remote Monitoring Reimbursement, T-cell Diagnostics And A Digital Health Feature
In this week's podcast, managing editor Marion Webb discusses a new monthly digital health roundup which will soon feature on Medtech Insight. Managing editor Reed Miller discusses reimbursement difficulties as it applies to remote cardiac monitoring. UK-based reporter Barnaby Pickering gives an overview of an interview with the chief medical officer of Adaptive Biotechnologies about its new T-Detect platform.
Coronavirus Notebook: Italy Makes First Use Of EU’s Vaccine Export Control System, More Regulators Issue Guidance On Variants
Ukraine has established a system for issuing emergency use authorizations for COVID-19 vaccines that recognizes authorizations granted by other world regulators.